C. Tang

发表

Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors.

S. Hubbard, J. Schlessinger, M. Mohammadi, 1997, Science.

P450 interaction with farnesyl-protein transferase inhibitors metabolic stability, inhibitory potency, and P450 binding spectra in human liver microsomes.

C. Tang, J. Lin, J. Wai, 2001, Biochemical pharmacology.

P-glycoprotein-mediated efflux of indinavir metabolites in Caco-2 cells expressing cytochrome P450 3A4.

J. Hochman, C. Tang, J. Lin, 2001, The Journal of pharmacology and experimental therapeutics.

Substrate inhibition kinetics for cytochrome P450-catalyzed reactions.

A. D. Rodrigues, C. Tang, T. Rushmore, 2001, Drug metabolism and disposition: the biological fate of chemicals.

Enzyme kinetics of cytochrome P450-mediated reactions.

A. D. Rodrigues, T. Baillie, C. Tang, 2012, Current drug metabolism.

The Stalk Region of the Escherichia coli ATP Synthase

C. Tang, R. Capaldi, Spencer D. Watts, 1996, The Journal of Biological Chemistry.

Design, synthesis, and evaluations of substituted 3-[(3- or 4-carboxyethylpyrrol-2-yl)methylidenyl]indolin-2-ones as inhibitors of VEGF, FGF, and PDGF receptor tyrosine kinases.

G. Mcmahon, L. Sun, C. Tang, 1999, Journal of medicinal chemistry.

Differences in the absorption, metabolism and biliary excretion of a diastereomeric pair of α v β 3 - antagonists in rat: limited role of P-glycoprotein

B. Ma, J. Hochman, C. Tang, 2002, Xenobiotica; the fate of foreign compounds in biological systems.

Characterization of the interface between gamma and epsilon subunits of Escherichia coli F1-ATPase.

C. Tang, R. Capaldi, 1996, The Journal of biological chemistry.

Hepatic metabolism of MK-0457, a potent aurora kinase inhibitor: interspecies comparison and role of human cytochrome P450 and flavin-containing monooxygenase.

C. Tang, T. Prueksaritanont, Cuyue Tang, 2007, Drug metabolism and disposition: the biological fate of chemicals.

Nonpeptide somatostatin agonists with sst4 selectivity: synthesis and structure-activity relationships of thioureas.

C. Tang, C. Stidsen, A. Crider, 1998, Journal of medicinal chemistry.

Identification of substituted 3-[(4,5,6, 7-tetrahydro-1H-indol-2-yl)methylene]-1,3-dihydroindol-2-ones as growth factor receptor inhibitors for VEGF-R2 (Flk-1/KDR), FGF-R1, and PDGF-Rbeta tyrosine kinases.

S. Hubbard, G. Mcmahon, L. Sun, 2000, Journal of medicinal chemistry.

Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases.

G. Mcmahon, L. Sun, C. Tang, 1998, Journal of medicinal chemistry.

Metabolic chiral inversion of stiripentol in the rat. II. Influence of route of administration.

T. Baillie, C. Tang, R. Levy, 1994, Drug metabolism and disposition: the biological fate of chemicals.

Metabolic chiral inversion of stiripentol in the rat. I. Mechanistic studies.

T. Baillie, C. Tang, R. Levy, 1994, Drug metabolism and disposition: the biological fate of chemicals.

In-vitro metabolism of celecoxib, a cyclooxygenase-2 inhibitor, by allelic variant forms of human liver microsomal cytochrome P450 2C9: correlation with CYP2C9 genotype and in-vivo pharmacokinetics.

A. D. Rodrigues, C. Tang, T. Rushmore, 2001, Pharmacogenetics.

Role of a potent inhibitory monoclonal antibody to cytochrome P-450 3A4 in assessment of human drug metabolism.

A. D. Rodrigues, T. Baillie, C. Tang, 1999, The Journal of pharmacology and experimental therapeutics.

Major role of human liver microsomal cytochrome P450 2C9 (CYP2C9) in the oxidative metabolism of celecoxib, a novel cyclooxygenase-II inhibitor.

A. D. Rodrigues, C. Tang, T. Rushmore, 2000, The Journal of pharmacology and experimental therapeutics.

The disulfide-rich region of platelet glycoprotein (GP) IIIa contains hydrophilic peptide sequences that bind anti-GPIIIa autoantibodies from patients with immune thrombocytopenic purpura (ITP).

C. Tang, D. Beardsley, B.-G. Chen, 2003, Biophysical chemistry.

Simultaneous determination of urinary free cortisol and 6beta-hydroxycortisol by liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry and its application for estimating hepatic CYP3A induction.

A. D. Rodrigues, C. Tang, I. Mcintosh, 2000, Journal of chromatography. B, Biomedical sciences and applications.

Metabolic interactions between mibefradil and HMG-CoA reductase inhibitors: an in vitro investigation with human liver preparations.

B. Ma, T. Baillie, C. Tang, 1999, British journal of clinical pharmacology.

Substrate-dependent effect of acetonitrile on human liver microsomal cytochrome P450 2C9 (CYP2C9) activity.

A. D. Rodrigues, C. Tang, Cuyue Tang, 2000, Drug metabolism and disposition: the biological fate of chemicals.

Comparison of imidazole- and 2-methyl imidazole-containing farnesyl-protein transferase inhibitors: interaction with and metabolism by rat hepatic cytochrome P450s.

J. Hochman, C. Tang, J. Lin, 2000, Drug metabolism and disposition: the biological fate of chemicals.

ntf1+ encodes a 6-cysteine zinc finger-containing transcription factor that regulates the nmt1 promoter in fission yeast.

P. Russell, C. Tang, A. Bueno, 1994, The Journal of biological chemistry.

Pyrene substituted terfluorenes: special influence of non-conjugated pyrene group on thermal and electroluminescent properties

C. Tang, Yong Xia, W. Huang, 2013 .

The phorbol ester 12-O-tetradecanoyl-phorbol-13-acetate stimulates the dephosphorylation of mitochondrial ferredoxin in cultured chick kidney cells.

S. Kain, C. Tang, H. Henry, 1993, Endocrinology.

Identification of S-(n-butylcarbamoyl)glutathione, a reactive carbamoylating metabolite of tolbutamide in the rat, and evaluation of its inhibitory effects on glutathione reductase in vitro.

T. Baillie, C. Tang, X. Guan, 1999, Chemical Research in Toxicology.